Autonomix Medical Expands U.S. Patent Protection for Neuromodulation
THE WOODLANDS, Texas, Aug. 26, 2026 Autonomix Medical, Inc. has expanded its intellectual property portfolio with the issuance of...
Catheter Technology
Advertisement
Autonomix Medical Completes GLP Study for FDA Submission
THE WOODLANDS, Texas, August 12, 2026 Autonomix Medical, Inc. announced the successful completion of a Good Laboratory Practice (GLP)...
Autonomix Medical Secures New U.S. Patent for Precision Neuromodulation Platform
THE WOODLANDS, Texas, July 23, 2026 Autonomix Medical, Inc. announced that it has been granted U.S. Patent No. 12,471,776,...
Autonomix Secures Canadian Patent for Neural Sensing
THE WOODLANDS, Texas, July 13, 2026 Autonomix Medical announced the grant of Canadian Patent No. 3,158,197, titled “Endoscopic Sympathectomy...
4DMedical Unlocks Advanced CT:VQ Imaging for Australia
MELBOURNE, Australia, June 29, 2026 4DMedical has achieved a major regulatory milestone with the Therapeutic Goods Administration (TGA) approving...
Advertisements
Terumo Completes First U.S. OPUSWAVE Imaging Procedure
SOMERSET, N.J., June 29, 2026 Terumo Interventional Systems (TIS), a division of Terumo Corporation, has announced the successful completion...
Artivion Brings FDA-Approved AMDS to U.S. Heart Centers
ATLANTA, Ga., June 29, 2026 Artivion, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted...
Jupiter Endovascular Reports Positive SPIRARE II Trial Results
MENLO PARK, Calif., May 20, 2026 Jupiter Endovascular announced positive topline results from the pivotal SPIRARE II clinical trial...
Corvention Wins FDA Clearance for KardiaPSI Balloon
FLAGSTAFF, Ariz., May 11, 2026 Corvention announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...
Advertisement
